UnitedHealth price target lowered to $560 from $610 at Argus

Argus lowered the firm’s price target on UnitedHealth (UNH) to $560 from $610 and keeps a Buy rating on the shares. The demographics of an aging population remain a favorable tailwind as the increasing population of older Americans will need health benefit plans and services to manage their healthcare needs, though in the near-term, the company faces pressures from elevated medical costs, the analyst tells investors in a research note.